Industry association · Austria · EU Transparency Register 22044375915-04
Counts here are a floor, never a total: they cover the 673 consultation files tracked so far (58,314 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Among the 1528 trade and business associations on this site, they rank #1439 by legislative files engaged, a count of participation, not a measure of influence.
Self-declared to the EU Transparency Register (snapshot 20 Oct 2026).
Self-declared to the EU Transparency Register (snapshot 20 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Österreichischer in PolicySpeak: request access →
Work at Österreichischer Generikaverband OeGV? so we know who speaks for it.
Österreichischer Generikaverband OeGV filed 1 position on 26 Jun 2025, across 1 of the 673 legislative files tracked here, attaching a full position paper 1 time.
Opinion of the pharmaceutical industry in Austria on the proposal for a Regulation COM(2025) 102 final (‘Critical Medicines Act’). Prepared by the Fachverband der Chemie Industrie (FCIO), the Austrian Association of generic medicines (OeGV) and PHARMIG Association of the Pharmaceutical Industry of Austria.
Filed in German · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Österreichischer Generikaverband OeGV next to another organization. Same files, same register facts, side by side. Compare →
Everything on this page comes from Österreichischer Generikaverband OeGV’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.